Introduction/Aim. Microencapsulation technology can be used
for the protection of alpha-tocopherol from degradation in
unfavorable environments and enhancement of bioavailability
and shelf-life of vitamin E. The aim of this study was the
synthesis and characterization of alginate microparticles
for the oral delivery of α-tocopherol.
Methods. Four different formulations of alpha-tocopherol
loaded calcium alginate microparticles for oral delivery
were synthesized by external ionotropic gelation method. The
vitamin E content in microparticles was 0.5%, 1% and 2%
(w/w); the vitamin E/sodium alginate ratio was 1:1 and 1:2.
All microparticles were characterized by average particles
size, swelling degree, vitamin E content, loading capacity,
and encapsulation efficiency.
Results. Spherically shaped microparticles with the diameter
of 500 to 1000 µm were obtained after the drying process.
The size and the swelling degree did not change
significantly in 0.1 M HCL, while they were increased in
base conditions of phosphate buffer of pH 6.8 and 7.4.
Encapsulated vitamin E content was not significantly
different between formulations (0.30 ± 0.010 - 0.60 ± 0.021
mg/mL). The loading capacities were in the range between 10
± 0.11% and 20.45 ± 0.22%, while encapsulation efficiency
percentages were between 18.94 ± 0.32% and 31.91 ± 0.41%.
Conclusion. The optimum conditions for alpha-tocopherol
encapsulation with the highest percentage of loading
capacity and encapsulation efficacy were obtained using 1%
sodium alginate, 2% calcium chloride, and vitamin E/polymer
in the ratio 1:1. All four formulations showed the expected
behavior in different mediums, which simulated
gastrointestinal fluids
in vivo (0.1 M
HCL, phosphate buffer pH 6.8 and pH 7.4): gastroresistance,
increasing in the size, and swelling degree in intestinal
fluids. This emphasizes the use of alginate microparticles
as a carrier for the oral delivery of vitamin E.
Keywords: alpha-tocopherol, vitamin E,
calcium alginate, alginate particles, encapsulation
Corresponding
author:
Ana Barjaktarević
e-mail:
ana.radovanovickg@gmail.com